1.
Rev. esp. enferm. dig
; 114(10): 628-629, octubre 2022. ilus
Artigo
em Inglês
| IBECS
| ID: ibc-210785
2.
Rev Esp Enferm Dig
; 114(10): 628-629, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35469405
RESUMO
Direct intestinal administration of levodopa-carbidopa gel has shown good results in selected patients with Parkinson's disease (1, 2). We want to present a complication related to the device necessary for the administration of this drug. A 58-year-old man, diagnosed with Parkinson's disease, treated for six months with levodopa-carbidopa intestinal gel, administered through a percutaneous endoscopic gastrostomy (PEG) tube with jejunal extension, presented at the emergency department for abdominal pain. The patient complained abdominal discomfort that lasted two months. It was described as pain around the umbilical area that radiated to the left lumbar region, worsened after ingestion, and did not subside with conventional analgesia.